POLARISqb, a Durham, North Carolina company developing a drug discovery platform using a quantum computer has raised a seed round of $2.1 million from investors OurCrowd and Infinity Medical. The POLARISqb software is designed to quickly screen through a billions of potential drug molecules to identify lead candidates for clinical trials and significantly improve drug discovery times. They indicate that their technology which combines cloud, quantum computing, artificial intelligence, and machine learning technologies can operate up to 10,000 times faster than alternative solutions. Additional details about this investment are available in a news release from POLARISqb available here.
August 10, 2021
